Patents by Inventor Maria Mendez-Lago

Maria Mendez-Lago has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKERS FOR NON-HODGKIN LYMPHOMAS AND USES THEREOF
    Publication number: 20220282336
    Abstract: The disclosure provides a method of identifying a subject as having B-cell non-Hodgkin lymphoma (NHL) such as testing a sample from a subject for a mutation in one or more biomarkers. Also described are methods for classifying or monitoring a subject having, or suspected of having, B-cell non-Hodgkin lymphoma comprising testing the sample for a mutation in one or more biomarkers.
    Type: Application
    Filed: May 9, 2022
    Publication date: September 8, 2022
    Inventors: Ryan D. MORIN, Marco A. MARRA, Andrew J. MUNGALL, Martin HIRST, Maria MENDEZ-LAGO, Randy D. GASCOYNE, Joseph M. CONNORS
  • Biomarkers for non-hodgkin lymphomas and uses thereof
    Patent number: 11326212
    Abstract: The disclosure provides a method of identifying a subject as having B-cell non-Hodgkin lymphoma (NHL) such as testing a sample from a subject for a mutation in one or more biomarkers. Also described are methods for classifying or monitoring a subject having, or suspected of having, B-cell non-Hodgkin lymphoma comprising testing the sample for a mutation in one or more biomarkers.
    Type: Grant
    Filed: October 1, 2018
    Date of Patent: May 10, 2022
    Assignee: British Columbia Cancer Agency Branch
    Inventors: Ryan D. Morin, Marco A. Marra, Andrew J. Mungall, Martin Hirst, Maria Mendez-Lago, Randy D. Gascoyne, Joseph M. Connors
  • BIOMARKERS FOR NON-HODGKIN LYMPHOMAS AND USES THEREOF
    Publication number: 20190153540
    Abstract: The disclosure provides a method of identifying a subject as having B-cell non-Hodgkin lymphoma (NHL) such as testing a sample from a subject for a mutation in one or more biomarkers. Also described are methods for classifying or monitoring a subject having, or suspected of having, B-cell non-Hodgkin lymphoma comprising testing the sample for a mutation in one or more biomarkers.
    Type: Application
    Filed: October 1, 2018
    Publication date: May 23, 2019
    Inventors: Ryan D. MORIN, Marco A. MARRA, Andrew J. MUNGALL, Martin HIRST, Maria MENDEZ-LAGO, Randy D. GASCOYNE, Joseph M. CONNORS
  • Biomarkers for non-hodgkin lymphomas and uses thereof
    Patent number: 10113199
    Abstract: The disclosure provides a method of identifying a subject as having B-cell non-Hodgkin lymphoma (NHL) such as testing a sample from a subject for a mutation in one or more biomarkers. Also described are methods of classifying or monitoring a subject having, or suspected of having, B-cell non-Hodgkin lymphoma comprising testing the same for a mutation in one or more biomarkers.
    Type: Grant
    Filed: May 20, 2014
    Date of Patent: October 30, 2018
    Assignee: British Columbia Cancer Agency Branch
    Inventors: Ryan D. Morin, Marco A. Marra, Andrew J. Mungall, Martin Hirst, Maria Mendez-Lago, Randy D. Gascoyne, Joseph M. Connors
  • Biomarkers for Non-Hodkin Lymphomas and Uses Thereof
    Publication number: 20140342920
    Abstract: The disclosure provides a method of identifying a subject as having B-cell non-Hodgkin lymphoma (NHL) such as testing a sample from a subject for a mutation in one or more biomarkers. Also described are methods of classifying or monitoring a subject having, or suspected of having, B-cell non-Hodgkin lymphoma comprising testing the same for a mutation in one or more biomarkers.
    Type: Application
    Filed: May 20, 2014
    Publication date: November 20, 2014
    Applicant: British Columbia Cancer Agency Branch
    Inventors: Ryan D. Morin, Marco A. Marra, Andrew J. Mungall, Martin Hirst, Maria Mendez-Lago, Randy D. Gascoyne, Joseph M. Connors
  • BIOMARKERS FOR NON-HODGKIN LYMPHOMAS AND USES THEREOF
    Publication number: 20130102477
    Abstract: The disclosure provides a method of identifying a subject as having B-cell non-Hodgkin lymphoma (NHL) such as testing a sample from a subject for a mutation in one or more biomarkers. Also described are methods for classifying or monitoring a subject having, or suspected of having, B-cell non-Hodgkin lymphoma comprising testing the sample for a mutation in one or more biomarkers.
    Type: Application
    Filed: June 23, 2011
    Publication date: April 25, 2013
    Inventors: Ryan D. Morin, Marco A. Marra, Andrew J. Mungall, Martin Hirst, Maria Mendez-Lago, Randy D. Gascoyne, Joseph M. Connors
  • Methods for mapping and sequencing nucleic acids
    Publication number: 20050214838
    Abstract: The present invention relates to methods and constructs for sequencing, mapping and ordering polynucleotide sequences. The invention finds particular applicability in analysis of repetitive DNA sequences such as heterochromatic sequences.
    Type: Application
    Filed: March 10, 2005
    Publication date: September 29, 2005
    Inventors: Waclaw Szybalski, Alfredo Villasante, Jadwiga Wild, Maria Mendez-Lago